Literature DB >> 3155592

The presence of cyclosporine in body tissues and fluids during pregnancy.

S M Flechner, A R Katz, A J Rogers, C Van Buren, B D Kahan.   

Abstract

A term pregnancy, labor, and delivery is reported in a cyclosporine- and prednisone-treated female cadaveric renal allograft recipient. A male child, small for gestational age at 2370 g, was born at 38 weeks of gestation with neither congenital anomalies nor nephrotoxicity or hepatotoxicity. Cyclosporine (CSA) concentrations as determined by a radioimmunoassay are reported in maternal and fetal tissues. CSA is present in the fetal circulation during gestation at similar concentrations to those in the mother. Fetal serum at birth displayed 25% suppression of a third-party mixed lymphocyte culture (MLC) compared with control incubations. CSA was present in maternal breast milk; therefore, breastfeeding of children by CSA-treated mothers should be avoided.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155592     DOI: 10.1016/s0272-6386(85)80138-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  19 in total

Review 1.  The cyclosporins.

Authors:  Z Rehácek
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 2.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

3.  Cyclosporine and its metabolites in mother and baby.

Authors:  R Venkataramanan; B Koneru; C C Wang; G J Burckart; S N Caritis; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Tumour induction by transplacental infection with polyoma virus of the F1 generation of Wistar rats.

Authors:  W Verhagen; C M Hubert; E Mohtaschem
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 5.  [Pregnancy under immunosuppression].

Authors:  J Walldorf; M M Dollinger; T Seufferlein
Journal:  Internist (Berl)       Date:  2011-10       Impact factor: 0.743

Review 6.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

7.  Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.

Authors:  Songmao Zheng; Thomas R Easterling; Karen Hays; Jason G Umans; Menachem Miodovnik; Shannon Clark; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

Review 8.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant.

Authors:  Irena Nulman; Michael Sgro; Maru Barrera; David Chitayat; John Cairney; Gideon Koren
Journal:  Paediatr Drugs       Date:  2010-04-01       Impact factor: 3.022

Review 10.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.